Dr. Christopher Longo
Professor / Executive Commitee Member, MHM Program
Health Policy & Management
Dr. Longo has over 25 years’ experience in clinical research, economic evaluation and access strategies for pharmaceuticals. He has published clinical, economic, and policy research in a number of therapeutic areas including: cancer, diabetes, sepsis, and mental health disorders. He teaches courses in health economics and population health at McMaster, as well as a 5-week module on health economics in public health at the Dalla Lana School of Public Health at the University of Toronto (2009-2016). Longo’s research has examined the economics of cancer and diabetes, economic evaluation of pharmaceuticals, global pharmaceutical pricing strategies, the public/private mix in the financing of healthcare, and the evaluation of factors influencing patients’ financial burden for health care services. Although still interested in these issues and how they relate to the healthcare system and its end users, he has refocused his research agenda. His current research examines the costs and economic evaluation of interventions/programs throughout the cancer journey, with the intent of informing policy decision making.